Moat Ross bought KNSA
September 1, 2026 · Form 4 insider transaction
Moat Ross bought 9,250 shares of Kiniksa Pharmaceuticals International, plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,250
Price
$0.00
Total value
N/A
InsiderMoat Ross
RoleOfficer
SecurityRestricted Share Unit
Transaction codeA: Grant or award
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after9,250
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.; The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2026.